Correction: Thymosin beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

Correction: Thymosin beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

[This corrects the article DOI: 10.1371/journal.pone.0110598.].

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4335037?pdf=render

Similar Items

Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
by: Chuanyu Wei, et al.
Published: (2014-01-01)

Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
by: Douglas Mesadri Gewehr, et al.
Published: (2021-11-01)

Captopril Attenuates Matrix Metalloproteinase-2 and -9 in Monocrotaline-Induced Right Ventricular Hypertrophy in Rats
by: Muneyoshi Okada, et al.
Published: (2008-01-01)

Correction: The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension.
by: PLOS ONE Staff
Published: (2016-01-01)

Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling
by: Akira Sugiyama, et al.
Published: (2020-09-01)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
by: Lei Yang, et al.
Published: (2023-02-01)

Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate
by: Marta Oknińska, et al.
Published: (2021-09-01)

Assessment of Right ventricular hypertrophy in pulmonary arterial hypertension – An echocardiographic study
by: M. Mohamed Iesa, et al.
Published: (2014-11-01)

Echocardiographic markers of pulmonary hemodynamics and right ventricular hypertrophy in rat models of pulmonary hypertension
by: Fotios Spyropoulos, et al.
Published: (2020-05-01)

Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension
by: Ivan S. Koklin, et al.
Published: (2019-09-01)

Correction: A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy.
by: Eric M Davis, et al.
Published: (2019-01-01)

Effects of Telmisartan on Right Ventricular Remodeling Induced by Monocrotaline in Rats
by: Muneyoshi Okada, et al.
Published: (2009-01-01)

Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma
by: W. Theunissen, et al.
Published: (2014-03-01)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
by: Olga Sadowska, et al.
Published: (2020-09-01)

Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
by: Igor Bastos Polonio, et al.
Published: (2014-08-01)

Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension.
by: Marc Revermann, et al.
Published: (2014-01-01)

Cardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in mice.
by: Noritada Yoshikawa, et al.
Published: (2012-01-01)

Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice
by: Vainchenker William, et al.
Published: (2007-01-01)

Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
by: Balram Neupane, et al.
Published: (2020-06-01)

Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension
by: Yen-Yu Lu, et al.
Published: (2022-09-01)

Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension
by: Eva Malikova, et al.
Published: (2022-02-01)

Role of oxidative stress versus lipids in monocrotaline‐induced pulmonary hypertension and right heart failure
by: Firoozeh Farahmand, et al.
Published: (2021-11-01)

The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure
by: Hyun Kyung Bae, et al.
Published: (2016-06-01)

Correction: Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity.
by: PLOS ONE Staff
Published: (2015-01-01)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
by: Lin Huang, et al.
Published: (2022-06-01)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
by: Yi Tang, et al.
Published: (2022-04-01)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018-09-01)

The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
by: Mohamed Izikki, et al.
Published: (2013-01-01)

Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01)

Comparative analysis of age in monocrotaline-induced pulmonary hypertensive rats
by: Akiko Kawade, et al.
Published: (2021-09-01)

Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Min Zhang, et al.
Published: (2019-01-01)

Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure
by: Thaïs Hautbergue, et al.
Published: (2021-06-01)

Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertension
by: Zhongkai Zhu, et al.
Published: (2020-08-01)

Association of Electrocardiographic Signs of Right Ventricular Hypertrophy and Clot Localization in Chronic Thromboembolic Pulmonary Hypertension
by: Sylwia Sławek-Szmyt, et al.
Published: (2022-01-01)

A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy.
by: Eric M Davis, et al.
Published: (2018-01-01)

Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice
by: Juliane Hannemann, et al.
Published: (2020-11-01)

Improvement in the electrocardiograms associated with right ventricular hypertrophy after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
by: Takahiko Nishiyama, et al.
Published: (2018-06-01)

Cannabidiol inhibits lung proliferation in monocrotaline-induced pulmonary hypertension in rats
by: Anna Krzyżewska, et al.
Published: (2023-03-01)

Fermented garlic extract ameliorates monocrotaline-induced pulmonary hypertension in rats
by: Byung Mun Park, et al.
Published: (2017-03-01)

Protective effect of triclosan in monocrotaline-induced pulmonary arterial hypertension: FASN inhibition a novel approach
by: Nimer Alsabeelah, et al.
Published: (2022-01-01)